• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges.

作者信息

Ninatti Gaia, Moresco Rosa Maria, Sollini Martina

机构信息

University of Milano-Bicocca, Monza, Italy.

Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1421-1422. doi: 10.1007/s00259-024-06591-3.

DOI:10.1007/s00259-024-06591-3
PMID:38191815
Abstract
摘要

相似文献

1
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges.异柠檬酸脱氢酶（IDH）抑制剂新时代下IDH突变型胶质瘤的分子成像：为未来挑战做准备
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1421-1422. doi: 10.1007/s00259-024-06591-3.
2
Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.使用酰胺质子转移加权（APTw）MRI 预测 II 级胶质瘤的 IDH 突变状态。
Magn Reson Med. 2017 Sep;78(3):1100-1109. doi: 10.1002/mrm.26820. Epub 2017 Jul 16.
3
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.使用标准临床磁共振成像表观扩散系数图像预测脑胶质瘤的基因型和生存：来自癌症基因组图谱的一项初步研究。
AJNR Am J Neuroradiol. 2018 Oct;39(10):1814-1820. doi: 10.3174/ajnr.A5794. Epub 2018 Sep 6.
4
The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH-mutant gliomas.氨基酸PET成像在预测和监测异柠檬酸脱氢酶（IDH）突变型胶质瘤中伏立西尼反应方面的潜力。
Neuro Oncol. 2024 Mar 4;26(3):403-406. doi: 10.1093/neuonc/noad240.
5
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors.IDH 突变型 gliomas 的分子生物学和新型治疗方法：IDH 抑制剂的新纪元。
Biochim Biophys Acta Rev Cancer. 2024 May;1879(3):189102. doi: 10.1016/j.bbcan.2024.189102. Epub 2024 Apr 21.
6
Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI.基于加速扩散张量成像的低级别胶质瘤分子亚型分类
AJNR Am J Neuroradiol. 2019 Sep;40(9):1458-1463. doi: 10.3174/ajnr.A6162. Epub 2019 Aug 14.
7
Biological tumour volumes of gliomas in early and standard 20-40 min F-FET PET images differ according to IDH mutation status.IDH 突变状态不同，早期和标准的 20-40 分钟 F-FET PET 图像中脑胶质瘤的生物肿瘤体积也不同。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1242-1249. doi: 10.1007/s00259-018-3969-4. Epub 2018 Feb 27.
8
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.2016 年 WHO 分级 II/III 级胶质瘤分类更新的影像学相关性：对 IDH、1p/19q 和 ATRX 状态的影响。
J Neurooncol. 2017 Dec;135(3):601-609. doi: 10.1007/s11060-017-2613-7. Epub 2017 Sep 4.
9
Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.胶质瘤分级和 IDH 状态解码的诊断性能比较：3D 酰胺质子转移 APT 与四种扩散加权 MRI 模型的比较。
J Magn Reson Imaging. 2022 Dec;56(6):1834-1844. doi: 10.1002/jmri.28211. Epub 2022 Apr 30.
10
The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.脑肿瘤全脑磁共振波谱成像与 IDH 突变状态的相关性。
J Neuroimaging. 2020 Jan;30(1):58-64. doi: 10.1111/jon.12685. Epub 2019 Dec 23.

本文引用的文献

1
What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?什么是异柠檬酸脱氢酶突变的世界卫生组织2级中枢神经系统胶质瘤，或者谁应该接受沃拉西尼布治疗？
Neuro Oncol. 2023 Nov 2;25(11):1915-1917. doi: 10.1093/neuonc/noad113.
2
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.沃拉西尼布治疗 IDH1 或 IDH2 突变型低级别胶质瘤。
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
3
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas.
突变型异柠檬酸脱氢酶（mIDH）作为脑胶质瘤 PET 成像的靶点。
Molecules. 2023 Mar 23;28(7):2890. doi: 10.3390/molecules28072890.
4
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review.PET成像在成人型弥漫性胶质瘤放疗后放射性坏死与疾病复发鉴别诊断中的作用：一项系统评价
Cancers (Basel). 2023 Jan 5;15(2):364. doi: 10.3390/cancers15020364.
5
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.术前[11C]蛋氨酸 PET 对低级别胶质瘤患者治疗决策的个体化作用。
Neuro Oncol. 2022 Sep 1;24(9):1546-1556. doi: 10.1093/neuonc/noac040.
6
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.沃拉西尼布，一种 IDH1/2 突变体的双重抑制剂，用于复发性或进行性脑胶质瘤；一项首次人体 I 期试验的结果。
Clin Cancer Res. 2021 Aug 15;27(16):4491-4499. doi: 10.1158/1078-0432.CCR-21-0611. Epub 2021 Jun 2.
7
Synthesis and Evaluation of a F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET.用于正电子发射断层扫描（PET）成像胶质瘤中突变型异柠檬酸脱氢酶1（IDH1）表达的F标记三嗪二胺类似物的合成与评价
ACS Med Chem Lett. 2018 May 1;9(7):606-611. doi: 10.1021/acsmedchemlett.7b00478. eCollection 2018 Jul 12.
8
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.氨基酸示踪剂在弥漫性低级别胶质瘤 PET 成像中的应用：术前应用的系统评价。
Acta Neurochir (Wien). 2018 Jul;160(7):1451-1460. doi: 10.1007/s00701-018-3563-3. Epub 2018 May 24.
9
Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.放射性标记抑制剂作为成像胶质瘤中突变型异柠檬酸脱氢酶1（IDH1）表达的探针：标记的丁基-苯基磺酰胺类似物的合成及初步评价
Eur J Med Chem. 2016 Aug 25;119:218-30. doi: 10.1016/j.ejmech.2016.04.066. Epub 2016 Apr 28.
10
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective.临床试验中胶质瘤的组织病理学诊断的观察者间变异性：临床医生的视角。
Acta Neuropathol. 2010 Sep;120(3):297-304. doi: 10.1007/s00401-010-0725-7. Epub 2010 Jul 20.